A Safe, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study
As part of our commitment to advancing science that brings real hope to people living with ME/CFS or Long Covid, Solve has selected Dr. Jay H. Chung (National Institutes of Health) as a recipient of our latest ME/CFS Catalyst Award. Dr. Chung’s groundbreaking study, “Mitochondrial Stabilizer IVO-21 As Therapy for ME/CFS,” is focused on developing […]
